Literature DB >> 10674492

Effects of retinoic acid and tumor necrosis factor alpha on GL-15 glioblastoma cells.

A M Chambaut-Guérin1, S L Costa, T Lefrançois, C Fages, X Gauthereau, M Tardy.   

Abstract

Glioblastomas are particularly resistant to classical antitumor treatments. Retinoids, which proved effective in the treatment of promyelocytic leukemia, have been used for clinical assays on glioma tumors with only moderate effects; however in some cases they were active in combination with another therapy. These observations prompted us to analyse the efficacy of combining retinoic acid (RA) with a cytokine on a clonal human glioma cell line. On GL-15 cells, RA and tumor necrosis factor alpha (TNFalpha) both reduced the glial fibrillary acidic protein level and DNA synthesis and induced apoptotic pathways, but they were significantly more effective when used together. The up-regulation of the p55 TNF receptors observed during RA exposure might explain this cooperative effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674492     DOI: 10.1097/00001756-200002070-00033

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

1.  Influence of whole peptidoglycan of bifidobacterium on cytotoxic effectors produced by mouse peritoneal macrophages.

Authors:  L S Wang; H M Zhu; D Y Zhou; Y L Wang; W D Zhang
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

Review 2.  Flavonoids and astrocytes crosstalking: implications for brain development and pathology.

Authors:  Jader Nones; Joice Stipursky; Sílvia Lima Costa; Flávia Carvalho Alcantara Gomes
Journal:  Neurochem Res       Date:  2010-03-09       Impact factor: 3.996

Review 3.  Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations.

Authors:  E N T Vikram; R Ilavarasan; R Kamaraj
Journal:  J Ayurveda Integr Med       Date:  2022-05-31

4.  Targeting A20 decreases glioma stem cell survival and tumor growth.

Authors:  Anita B Hjelmeland; Qiulian Wu; Sarah Wickman; Christine Eyler; John Heddleston; Qing Shi; Justin D Lathia; Jennifer Macswords; Jeongwu Lee; Roger E McLendon; Jeremy N Rich
Journal:  PLoS Biol       Date:  2010-02-23       Impact factor: 8.029

5.  13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.

Authors:  Siew-Ju See; Victor A Levin; W-K Alfred Yung; Kenneth R Hess; Morris D Groves
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.